Etretinate and the risk for teratogenicity: drug monitoring in a pregnant woman for 9 months after stopping treatment.
Vahlquist
A
A
Rollman
O
O
D000014:Abnormalities, Drug-Induced / Q000175:diagnosis*; D000328:Adult; D005050:Etretinate / Q000032:analysis*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011296:Prenatal Diagnosis; D012307:Risk Factors
D005050:Etretinate